NEURAXIS, INC. Cash and Cash Equivalents
NEURAXIS, INC. (NRXS) had Cash and Cash Equivalents of $8.32 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-11
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $8.32M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $7.08M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $4.97M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $4.38M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $8.32M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $7.08M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $4.97M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $4.38M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $5.99M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $2.01M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $3.70M 10-K · filed 2026-03-19 |
| 2024-09-30 | $260.88K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.77M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $81.75K 10-Q · filed 2024-05-20 |
| 2023-12-31 | $78.56K 10-K · filed 2025-03-20 |
| 2023-09-30 | $761.25K 10-K · filed 2024-04-16 |
| 2023-06-30 | $51.44K 10-Q · filed 2023-09-22 |
| 2022-12-31 | $253.70K 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |